Transplanting One Problem for Another.
作者信息
Borst Alexandra J, Wechsler Daniel S
机构信息
Pediatric Hematology-Oncology, Duke University Medical Center, Durham, North Carolina.
Pediatric Hematology-Oncology, Duke University Medical Center, Durham, North Carolina
出版信息
Pediatrics. 2017 May;139(5). doi: 10.1542/peds.2017-0542.
Abstract
摘要
相似文献
1
Transplanting One Problem for Another.
Pediatrics. 2017 May;139(5). doi: 10.1542/peds.2017-0542.
2
An act (Chapter No. 3) to prohibit commercial dealings in human organs intended for transplanting; to prohibit the transplanting of such organs between persons who are not genetically related; and for connected purposes. Dated 16 March 1993. (The Human Organ Transplants Act 1993).
Int Dig Health Legis. 1996;47(2):169-70.
3
A double-edged sword: once again optimism is high about transplanting animal organs into humans.
New Sci. 1998 Aug 8;159(2146):3.
4
The xeno-solution: perils and promise of transplanting animal organs into people.
Sci News. 1995 Nov 4;148(19):298-301.
5
The problem of cancer in organ transplant recipients: an overview.
Transplant Sci. 1994 Sep;4(1):23-32.
6
Transplanting suboptimum organs: medico-legal implications.
Lancet. 2015 Aug 22;386(9995):719-21. doi: 10.1016/S0140-6736(15)61413-1.
7
Transplanting allografts.
J Am Coll Surg. 2005 Jul;201(1):5-6. doi: 10.1016/j.jamcollsurg.2005.02.008.
8
Presumed consent in the law of the Russian Federation on transplanting organs.
Med Law. 2007 Mar;26(1):179-88.
9
The viability of transplanting organs from donors who underwent cardiopulmonary resuscitation: A systematic review.
Resuscitation. 2016 Nov;108:27-33. doi: 10.1016/j.resuscitation.2016.07.229. Epub 2016 Aug 24.
10
Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.
JAMA Oncol. 2016 Apr;2(4):463-9. doi: 10.1001/jamaoncol.2015.5137.
本文引用的文献
1
Cancer Risk After Pediatric Solid Organ Transplantation.
Pediatrics. 2017 May;139(5). doi: 10.1542/peds.2016-3893.
2
Research priority setting in organ transplantation: a systematic review.
Transpl Int. 2017 Apr;30(4):327-343. doi: 10.1111/tri.12924. Epub 2017 Feb 21.
3
OPTN/SRTR 2015 Annual Data Report: Economics.
Am J Transplant. 2017 Jan;17 Suppl 1:425-502. doi: 10.1111/ajt.14130.
4
Health-related quality of life after pediatric liver transplantation: A systematic review.
Liver Transpl. 2017 Mar;23(3):361-374. doi: 10.1002/lt.24696.
5
HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act.
Front Immunol. 2016 Dec 7;7:575. doi: 10.3389/fimmu.2016.00575. eCollection 2016.
6
Cancers Related to Immunodeficiencies: Update and Perspectives.
Front Immunol. 2016 Sep 20;7:365. doi: 10.3389/fimmu.2016.00365. eCollection 2016.
7
De Novo Malignancies After Transplantation: Risk and Surveillance Strategies.
Med Clin North Am. 2016 May;100(3):551-67. doi: 10.1016/j.mcna.2016.01.006. Epub 2016 Mar 17.
8
Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States.
Transplantation. 2016 Apr;100(4):879-85. doi: 10.1097/TP.0000000000001057.
9
Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology.
Crit Rev Oncog. 2015;20(3-4):315-27. doi: 10.1615/critrevoncog.2015013861.
10
Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant.
Prog Transplant. 2015 Jun;25(2):182-8. doi: 10.7182/pit2015826.
Zotero 插件